Progression of type 2 helper T celletype inflammation and airway remodeling in a rodent model of naturally acquired subclinical primary pneumocystis infection
Artículo

Open/Download
Publication date
2018Metadata
Show full item record
Cómo citar
Iturra, Pablo
Cómo citar
Progression of type 2 helper T celletype inflammation and airway remodeling in a rodent model of naturally acquired subclinical primary pneumocystis infection
Author
Abstract
Subclinical primary Pneumocystisinfection is the most common pulmonary infection in early infancy, making
it important to determine whether it damages the lung. Pneumocystis peaks at 2 to 5 months of age, when
respiratory morbidity coincidently increases. We have documented that Pneumocystis increases mucus
production in infant lungs, and animal models reveal lung lesions that warrant characterization. Herein,
immunocompetent rats infected at birth with Pneumocystis by cohabitation, to resemble communityacquired
infection, underwent lung assessments at 45, 60, and 75 days of age. Lungs fixed by vascular
perfusion to prevent collapse during necropsy were used for morphometry evaluations of mucus production,
airway epithelial thickening, perivascular and peribronchiolar inflammation, and structural airway remodeling.
Changes in these histologic features indicate lung disease. Selected immune markers were assessed in
parallel using fresh-frozen lung tissue from sibling rats of the same cages. Sequential activation of NF-kB and
an increased Gata3/T-bet mRNA level ratio, consistent with a type 2 helper T-celletype inflammatory
response, and subacute fibrosis were recognized. Therefore, documenting subclinical Pneumocystisinfection
induces lung disease in the immunocompetent host. Taken together with the peak age of primary Pneumocystisinfection,
results warrant investigating the clinical impact of this often subclinical infection on the
severity of respiratory diseases in early infancy. This model can also be used to assess the effects of airway
insults, including coinfections by recognized respiratory pathogens. (Am J Pathol 2018, 188: 417e431;
https://doi.org/10.1016/j.ajpath.2017.10.019)
Patrocinador
e Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT-Chile) grants 1100225 and 1140412 (S.L.V.), Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) under ERANet LAC grant ELAC2014/HID-0254 (S.L.V.), FONDECYT-Chile Postdoctoral Fellow grant 3140391 (D.A.R.), and the Chilean Doctoral Scholarship Fund (P.A.I., F.J.P., and A.M.)
Indexation
Artículo de publicación ISI
Quote Item
The American Journal of Pathology Vol. 188, No. 2, February 2018
Collections
The following license files are associated with this item: